The information provided is for convenience only. It is not investment advice or a recommendation, it does not constitute a solicitation to buy or sell securities, and it may not be relied upon in considering an investment in a Cardone fund. Past performance is no guarantee of future results. Any historical returns expected returns or probability projections may not reflect actual future performance. All securities involve risk and may result in partial or total loss. Investment in Cardone funds is available only to independently verified “accredited investors” through an offering made in accordance with Rule 506(c) under Regulation D of the Securities Act of 1933. Before investing in any Cardone fund, prospective investors should consider carefully the investment objective(s), risks, arches, and expenses. While the data we use from third parties is believed to be reliable, we cannot ensure the accuracy or completeness of the data provided. Cardone Capital does not provide legal or tax advice. Prospective investors should consult with a tax or legal adviser before making any investment decision.

How David C. Karli Became a Professional Doctor

In this Show

David C. Karli became more serious about becoming a professional doctor back in 2005. There was some research in the veterinary world which sparked his interest early on. Back then the therapeutic practice was very limited so he worked with what he had and went day by day. His journey was a long one to make sure that therapeutic medicine was approved and safe.

As time passed he observed that the growth curve with biologics grew exponentially but instead of dropping off, it just leveled off. Now, it has been growing and gaining gradual momentum, suggesting sustainability in the field. When he saw that reaction in a very conservative medical community he knew at that moment that biologics was here to stay. David C. Karli now continues to work on and progress his journey moving forward.

Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here:

(Visited 54 times, 1 visits today)